Incyte Email Format

Pharmaceutical ManufacturingDelaware, United States1001-5000 Employees

Incyte is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with unmet medical needs. Its portfolio centers on oncology and inflammatory conditions, including dermatology, with an emphasis on first-in-class therapies developed largely in-house. Headquartered in Wilmington, Delaware, the company operates across North America, Europe, and Asia and maintains a substantial, multinational workforce.
The company aims to improve patient lives by advancing therapies through science-driven discovery and development. In mid-2026, Mirum Pharmaceuticals and Incyte reported positive Phase 2 data for zilurgisertib in fibrodysplasia ossificans progressiva and noted that the FDA had begun Priority Review of the related NDA with a September 2026 decision date.

Sign up for free to view info

Company overview Employee directory